ArticleJournal of hepatocellular carcinoma2023

Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience.

Xian Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.